Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

6 July 2020

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer. This marks the first immunotherapy approved for this patient population as a first-line treatment and which is administered to patients without also giving chemotherapy.
- Read more about COVID-19 vaccine may launch by 15th August in India
ICMR has partnered with Bharat Biotech lnternational Limited (BBIL) to fast-track clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID Vaccine) and its clinical trials were approved by DCGI by end of June.
- Read more about Sun Pharma announces Japan MHLW approval of ILUMYA for the treatment of Plaque Psoriasis
Sun Pharma and includes its subsidiaries and/or associate companies) announced that one of its wholly-owned subsidiaries has received approval from the Ministry of Health, Labour and Welfare (MHLW), Japan for ILUMYA (tildrakizumab) for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies. Japan has approximately 430,000 people currently suffering from psoriasis.
- Read more about DCGI gives approval for human clinical trials of COVAXIN
Drug Controller General of India (DCGI) has given approval for human clinical trials of COVAXIN, the first potential COVID-19 Vaccine developed in India. The potential vaccine has been developed by Hyderabad-based Bharat Biotech, in association with Indian Council for Medical Research (ICMR). Human Trials for Phase I and Phase II are scheduled to start across the country from next month.
- Read more about INST synthesises inorganic-organic hybrid compound that can inhibit breast, lung & liver cancer cells
Scientists from the Institute of Nano Science & Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology Government of India, have synthesized a novel inorganic-organic hybrid compound that can inhibit breast, lung, and liver cancer cells, opening up new possibilities for metallodrugs.
- Read more about Hindustan Unilever completes acquisition of Vwash from Glenmark Pharmaceuticals
Hindustan Unilever Limited (HUL) announced that it has completed the acquisition of intimate hygiene brand VWash from Glenmark Pharmaceuticals Ltd. This acquisition was announced on March 23, 2020 and was subject to certain closing conditions, which have now been fulfilled.
- Read more about AI, Mobile Technology & Medical Healthcare equipment put forth a tremendous opportunity for Health Care Services
Sharing of Health Data of Public and Pvt Hospitals critical to development of Digital Health in India and it can go a long way in forecasting and managing Pandemics: Mahendra Singh Expert Member for Digital Health, WHO Global Digital Health, WHO Geneva
- Read more about FDA Approves New Therapy for Dravet Syndrome
The U.S. Food and Drug Administration approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy. It is often characterized by severe and unrelenting seizures despite medical treatment.
- Read more about New biomolecules to fight drug resistance in Kala-azar
TLeishmaniasis is a neglected tropical disease affecting almost 100 countries including India. It is caused by a parasite called Leishmania, which is transmitted through the bite of sand flies.
- Read more about IIT Guwahati develops point-of-care device to detect diabetic retinopathy